Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
Keyword(s):
Phase 2
◽
2011 ◽
Vol 11
(6)
◽
pp. 753-759
◽
Keyword(s):
Keyword(s):
2002 ◽
Vol 8
(12)
◽
pp. 1492-1494
◽
1991 ◽
Vol 142
(6)
◽
pp. 469-474
◽
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 40
(2)
◽
pp. 60-64
Keyword(s):
2012 ◽
Vol 93
(3)
◽
pp. 330-339
◽
Keyword(s):
Keyword(s):
Keyword(s):